Specialised heart valve clinics result in greater adherence to guideline-directed care: a comparative study

Natalie Montarello1, Curtis Page2, Sophie Bennett2

  • 1Cardiovascular Directorate, Guy's and St Thomas' Hospitals NHS Trust, London, England, UK nataliemontarello@gmail.com.

Open Heart
|March 31, 2026
PubMed

Insights

Patients with heart valve disease (HVD) treated outside specialist heart valve clinics (SHVC) receive suboptimal care. This study highlights the critical importance of SHVCs for optimal HVD management and patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Health Services Research

Background:

  • International guidelines recommend specialist heart valve centres (HVC) and clinics (SHVC) for optimal heart valve disease (HVD) care.
  • This study aimed to validate the importance of SHVCs within our institution.

Purpose of the Study:

  • To compare the quality of care for HVD patients managed within a specialist heart valve clinic (SHVC) versus those managed in non-specialist settings (N-SHVC).
  • To assess adherence to international guidelines for HVD management, including follow-up, investigations, surgical timing, and valve care advice.

Main Methods:

  • Retrospective review of 3731 consecutive non-SHVC patients over 18 months.
  • Comparison of 134 HVD patients from N-SHVC settings with 173 consecutive SHVC attendees.
  • Concordance defined by adherence to recommended HVD care protocols; discordance by any deviation.

Main Results:

  • HVD patients in N-SHVC settings showed significant discordance in management (38.2% native valve, 84.4% prior surgery) compared to SHVC patients (3.3% native valve, 4% prior surgery).
  • N-SHVC patients had less documented symptomatic correlation to HVD (31.5% vs 5.7%), infrequent exercise testing (3.4% vs 32%), and lower surgical referral rates (3.4% vs 26.8%).
  • No N-SHVC patients with prior valve surgery received endocarditis prevention advice, unlike 100% of SHVC patients.

Conclusions:

  • A significant proportion of HVD patients (almost 5%) are managed in non-specialist settings, receiving suboptimal care despite SHVC availability.
  • This underscores the necessity of SHVCs for ensuring guideline-adherent and optimal management of heart valve disease.
  • Centralizing HVD care within SHVCs is crucial for improving patient outcomes and adherence to best practices.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
496
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
583
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
466
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
554
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
378